Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stock Upgrades: Get Ahead of Tomorrow by Buying CSX Corp Today


Wall Street ratings agencies set the tone for today's stock market.

Stocks were carried out feet first after Russia was kicked out of the G7. (Presumably, given Comrade Putin's pinko politics, with a good stiff whack from the soul of My Left Foot. That is, unless someone suddenly found Nikita Khrushchev's footwear.) One thing is clear -- namely, that no one was watching that Daniel Day-Lewis film on Netflix (NASDAQ:NFLX), which nose-dived an S&P 500 (INDEXSP:.INX)-worst 6.67% and is sliding an additional 7.20% even as we speak. Herbalife (NYSE:HLF) bucked a remorseless tide of red ink, surging 6.70% after more existential agitating from Carl Icahn. The hedge fund honcho was actually an unlikely philosophy major, whose 1957 Princeton thesis went by the name of "The Problem of Formulating an Adequate Explication of the Empiricist Criterion of Meaning." So much for that carefully cultivated image of a Brooklyn street scrapper. As such, a penny for his thoughts as Descartes Systems (NASDAQ:DSGX), a software services stock named after a 17th-century French philosopher, fell 1.44% despite a broker boost. Can it really be possible that Rene is trailing Spinoza in the March Madness Overrated Philosophers Bracket? Surely it Kant. Elsewhere, much like the empiricists, Hewlett-Packard (NYSE:HPQ) CEO Meg Whitman has many more questions than answers. This, as the stock lost 1.00% on her imprecise response to a recent inquiry. As Janet Yellen could have told her, stay on script. It is always the questions that get you into trouble.
Today in economics, new home sales for February and March consumer confidence are each out at 10:00 a.m. Eastern. In earnings action, Carnival Corp (NYSE:CCL), Steelcase (NYSE:SCS), and Walgreen (NYSE:WAG) all release results.
Akzo Nobel (OTCMKTS:AKZOY): Citigroup puts the stock on its Focus List Europe of favored continental equities.
BMW Group (OTCMKTS:BAMXY): The German car giant gets upgraded to Buy from Neutral at Bank of America Merrill Lynch.
CSX Corp. (NYSE:CSX): Bank of America Merrill adds the railroad operator, whose catchphrase is "How Tomorrow Moves," to its US 1 List this morning.
Domtar (NYSE:UFS): Shares get boosted to Buy from Neutral at Goldman Sachs, which also increases its price objective to $138 from $100.
Endocyte (NASDAQ:ECYT): Biotech meltdown -- what biotech meltdown? The stock is surging some 11.20% today after being added to the Best Ideas List with Wedbush.
Mercer International (NASDAQ:MERC): MERC is moved to Hold from Reduce at TD Securities.
MSCI Inc. (NYSE:MSCI): Shares are now Neutral from Buy at UBS.
Orange (NYSE:ORAN): Kepler increases French telecom titan ORAN to Hold from Reduce.
Palo Alto Networks (NYSE:PANW): Citing a quicker-than-expected adoption of PANW's products, FBR Capital increases its investment assessment to Outperform from Perform. Its objective, previously $80, gets taken up by $10.
PACCAR (NASDAQ:PCAR): Goldman Sachs gives the stock a Buy-from-Neutral boost, taking its target price to $80 from $74.
Rackspace (NYSE:RAX): Morgan Stanley moves the cloud computing stock to Overweight from Equal-Weight.
ReneSola (NYSE:SOL): Roth Capital raises its recommendation to Buy from Neutral.
SABMiller (OTCMKTS:SBMRY): The brewing behemoth, whose other brands include Grolsch, Peroni, and Pilsner Urquell, gets upgraded to Outperform from Market Perform by Sanford Bernstein.

Also see:

New Stock Coverage: Forget Google Glass -- Is FireEye Worth Another Look?

Stock Downgrades: JPMorgan Drives the Corner Store Round the Bend
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos